Used in cancer research, particularly in the development of chemotherapy agents. Shows potential as an antimitotic agent by stabilizing microtubules, leading to inhibition of cell division in tumor cells. Studied for its activity against various cancer cell lines, including ovarian, breast, and lung cancers. Due to its structural similarity to paclitaxel, it serves as a valuable intermediate in the synthesis of taxane-based anticancer drugs. Also investigated for improved solubility and reduced resistance profiles compared to existing taxanes.